SCHEMBL19909037

SCHEMBL19909037

N#Cc1cc(-n2c3ccccc3c3cc(C#N)ccc32)c(-c2ccncc2)c(-n2c3ccccc3c3cc(C#N)ccc32)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 4/20 0.38
CSNK1A1 P48729 1/20 0.38
CSNK1D P48730 1/20 0.38
FLT3 P36888 2/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
PTGER4 P35408 2/20 0.36
ENPP3 O14638 1/20 0.36
CYP19A1 P11511 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
SLC6A2 P23975 1/20 0.35
PKN1 Q16512 1/20 0.35
PKN2 Q16513 1/20 0.35
CHUK O15111 1/20 0.34
USP2 O75604 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
CASP1 P29466 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21757798 0.94 MAPK14 (0.40) MAPK14CSNK1A1CSNK1DFLT3ABCG2
SCHEMBL19908950 0.94 CSNK1A1 (0.41) MAPK14CSNK1A1CSNK1DFLT3CYP19A1
SCHEMBL19909035 0.93 FLT3 (0.38) MAPK14CSNK1A1CSNK1DFLT3ABCG2
SCHEMBL19908925 0.92 MAPK14 (0.39) MAPK14CSNK1A1CSNK1DFLT3PTGER4
SCHEMBL19913155 0.90 MAPK14 (0.35) MAPK14CSNK1A1CSNK1DFLT3ABCG2
SCHEMBL19913148 0.90 MAPK14 (0.35) MAPK14CSNK1A1CSNK1DFLT3ABCG2
SCHEMBL19909475 0.90 CYP1A2 (0.40) MAPK14FLT3ABCG2USP2CYP1A2
SCHEMBL19909114 0.89 MAPK14 (0.39) MAPK14CSNK1A1CSNK1DFLT3ABCG2
SCHEMBL19913139 0.89 MAPK14 (0.37) MAPK14CSNK1A1CSNK1DFLT3ABCG2
SCHEMBL19909350 0.89 MAPK14 (0.39) MAPK14CSNK1A1CSNK1DFLT3ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 MAPK14 2544/4885CSNK1A1 4231/4885CSNK1D 3662/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 MAPK14 2544/4885CSNK1A1 4231/4885CSNK1D 3662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.